Skip to content
healthcare.dev

GLYCOPYRROLATE

NDC 75834-194, glycopyrrolate, injection, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-194
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-194 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCOPYRROLATE.2 mg/mL

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]

Package NDCNDC-11Package
75834-194-257583401942525 VIAL, SINGLE-DOSE in 1 CARTON (75834-194-25) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177

Use it

Look up 75834-194 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-194 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-194. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.